Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndrome.
Zhenli LiuShan LiangXinhuan WeiXiaofei DuJing ZhangPublished in: BMC gastroenterology (2022)
Defibrotide could improve the outcome of monocrotaline-induced rat HSOS indicating that defibrotide might be a better choice than LMWH in clinical practice.